Impella 5.5® with SmartAssist® Heart Pump

Minimally Invasive Heart Pump Providing Full Support with Maximum Unloading

Overview

Impella 5.5® with SmartAssist® delivers full cardiac support with maximum unloading providing upto 5.5 L/min of forward flow, allowing the heart to rest and recover. It is a microaxial, surgically inserted heart pump that unloads the left ventricle, reduces ventricular work, and provides the circulatory support necessary to allow recovery and early assessment of residual myocardial function. It is designed for longer-duration support and enables ambulation to optimize recovery while using real-time SmartAssist intelligence.

The Impella 5.5 with SmartAssist is now simpler to insert and easier to set-up and allows to use familiar surgical skills for insertion via the axillary artery or anterior aorta. Position confidently with the improved aortic placement signal, which also enables repositioning without imaging in the ICU*. Sidearm, tubing, and catheter lock improvements facilitate patient management. The new design for heparin-free purge with sodium hydrogencarbonate (“bicarb”) purge solution can simplify anticoagulation management in patients how do not tolerate heaprine in the purge solution.

Optimized Patient Management Through Further Developed Pump Key Figures

The enhanced pump metrics of the Impella 5.5 with SmartAssist facilitate the use of the heart pump and provide improved patient outcomes due to the cloud-based remote monitoring with Impella Connect® technology. Further developed pump metrics facilitate patient management. For example, they assist in pump positioning and in the weaning phase, thus helping to optimize native cardiac recovery and outcome.

Impella 5.5 with SmartAssist Experience Summary

 

Additional Resources

Discover What's New! Download the Product Comparision Guide of 1st Generation and 2nd Generation Products

Download

Download the datsheet for Impella 5.5 with SmartAssist.

Download

Heparin-Free Purge for Impella CP® with SmartAssist® and Impella 5.5® with SmartAssist® Heart Pumps

Download

Accessories and Ordering Information

Impella 5.5 SmartAssist Set
Automated Impella® Controller(AIC)
Placement Wire
Purge Cassette

Indications for Use EU

INDICATIONS FOR USE EU

The Impella 5.5® with SmartAssist® heart pump is an intracardiac pump for supporting the left ventricle. It is intended for clinical use in cardiology and in cardiac surgery for up to 30 days for the following indications, as well as others:
• The Impella 5.5 with SmartAssist is a cardiovascular support system for patients with reduced left ventricular function, e.g., post-cardiotomy, low output syndrome, cardiogenic shock after acute myocardial infarction.
• The Impella 5.5 with SmartAssist may also be used as a cardiovascular support system during coronary bypass surgery on the beating heart, particularly in patients with limited preoperative ejection fraction with a high risk of postoperative low output syndrome.

CONTRAINDICATIONS EU

The Impella 5.5® with SmartAssist® heart pump is contraindicated for the following situations:
• Mechanical aortic valves, severe aortic valvular stenosis
• Hematological disorder causing fragility of the blood cells or hemolysis
• Hypertrophic obstructive cardiomyopathy (HOCM)
• Aneurysm or necrotomy or severe anomaly of the ascending aorta and/or the aortic arch
• Mural thrombus in the left ventricle
• Ventricular septal defect (VSD) after myocardial infarction
• Anatomic conditions precluding insertion of the pump

POSSIBLE COMPLICATIONS EU

There are risks of complications with every procedure using a blood pump.
These include among others:
• Acute renal dysfunction
• Aortic valve injury
• Cardiogenic shock
• Cerebral Vascular Accident/Stroke
• Myocardial infarction
• Renal failure
• Thrombocytopenia
• Hemolysis
• Bleeding
• Limb Ischemia
• Immune reaction
• Embolism, thrombosis
• Cardiac or vascular injury (including ventricular perforation)
• Positioning problems causing haemolysis or reduced haemodynamic support
• Infection and septicemia
• Dislocation of the pump
• Cardiovalvular injuries due to extreme movement of the suction cannula in relation to the cardiac valve or as a result of attachment by suction of the pump to the valve system following incorrect positioning
• Endocardiac injuries as a result of attachment of the pump due to suction
• Pump failure, loss of pump components following a defect
• Patient dependency on the pump after use for support

NOTE

*Only for use in ventricular pumps

**StatLock is a trademark of Becton, Dickinson and Company

IMP-4908

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].